More EMvision Medical Devices Ltd. news
EMvision Medical Devices Ltd.ASX: EMV

S&P DJI Announces March 2022 Quarterly Rebalance

Mar 4, 2022 at 6:22 AM EST · Issued by EMvision Medical Devices Ltd.

Filed with ASX · Mar 4, 2022 at 6:22 AM EST · 10 pages · English

On 6ix: 6ix.com/news/sandp-dji-announces-march-2022-quarterly-rebalance-59

EMvision Medical Devices Ltd. on 6ix

Story so far

  • S&P DJI Announces March 2021 Quarterly RebalanceMar 12, 2021

Earlier from EMvision Medical Devices

  • Application for quotation of securities - EMVDec 22, 2021
  • EMV Technology to be Presented at Prestigious ConferenceDec 8, 2021
  • EMVision Receives $3.4m Non-Dilutive Funding this QuarterDec 7, 2021
  • Notification regarding unquoted securities - EMVDec 1, 2021
  • Clinical Trial Data Drives Confidence for Expanded StudiesNov 29, 2021

Later from EMvision Medical Devices

  • New Appointments to Clinical Advisory BoardMar 8, 2022
  • EMVision Secures Strategic Agreement With KeysightMay 4, 2022
  • Pause in TradingMay 16, 2022
  • EMVision Awarded $5m Non-Dilutive Funding via MMI GrantMay 17, 2022
  • EMVision Achieves First Responder MilestoneJun 26, 2022
All EMvision Medical Devices news releases↗

Follow EMvision Medical Devices into a list and get an email when it puts out news.

Follow EMvision Medical Devices
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer